메뉴 건너뛰기




Volumn 93, Issue 4, 2008, Pages 633-634

Relapse and death during first remission in acute myeloid leukemia

Author keywords

Acute myeloid leukemia; Complete remission; Death in remission; Relapse

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE;

EID: 42449113040     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12366     Document Type: Letter
Times cited : (23)

References (12)
  • 1
    • 0024458031 scopus 로고
    • On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: A randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group
    • Lowenberg B, Zittoun R, Kerkhofs H, Jehn U, Abels J, Debusscher L, et al. On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group. J Clin Oncol 1989;7:1268-74.
    • (1989) J Clin Oncol , vol.7 , pp. 1268-1274
    • Lowenberg, B.1    Zittoun, R.2    Kerkhofs, H.3    Jehn, U.4    Abels, J.5    Debusscher, L.6
  • 2
    • 0025138479 scopus 로고
    • Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly
    • Tilly H, Castaigne S, Bordessoule D, Casassus P, Le Prise PY, Tertian G, et al. Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly. J Clin Oncol 1990;8:272-9.
    • (1990) J Clin Oncol , vol.8 , pp. 272-279
    • Tilly, H.1    Castaigne, S.2    Bordessoule, D.3    Casassus, P.4    Le Prise, P.Y.5    Tertian, G.6
  • 3
    • 0036862084 scopus 로고    scopus 로고
    • The difficult problem of acute myeloid leukemia in the older adult
    • Stone RM. The difficult problem of acute myeloid leukemia in the older adult. CA Cancer J Clin 2002;52:363-71.
    • (2002) CA Cancer J Clin , vol.52 , pp. 363-371
    • Stone, R.M.1
  • 4
    • 34249810897 scopus 로고    scopus 로고
    • Acute myeloid leukemia and myelodysplastic syndromes in older patients
    • Estey E. Acute myeloid leukemia and myelodysplastic syndromes in older patients. J Clin Oncol 2007;25:1908-15.
    • (2007) J Clin Oncol , vol.25 , pp. 1908-1915
    • Estey, E.1
  • 5
    • 35048820182 scopus 로고    scopus 로고
    • Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia
    • Baz R, Rodriguez C, Fu AZ, Jawde RA, Kalaycio M, Advani A, et al. Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia. Cancer 2007;110:1752-9.
    • (2007) Cancer , vol.110 , pp. 1752-1759
    • Baz, R.1    Rodriguez, C.2    Fu, A.Z.3    Jawde, R.A.4    Kalaycio, M.5    Advani, A.6
  • 6
    • 33644521267 scopus 로고    scopus 로고
    • Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: Predictive prognostic models for outcome
    • Kantarjian H, O'Brien S, Cortes J, Giles F, Faderl S, Jabbour E, et al. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome. Cancer 2006;106:1090-8.
    • (2006) Cancer , vol.106 , pp. 1090-1098
    • Kantarjian, H.1    O'Brien, S.2    Cortes, J.3    Giles, F.4    Faderl, S.5    Jabbour, E.6
  • 7
    • 33947499161 scopus 로고    scopus 로고
    • Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia
    • Etienne A, Esterni B, Charbonnier A, Mozziconacci MJ, Arnoulet C, Coso D, et al. Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia. Cancer 2007;109:1376-83.
    • (2007) Cancer , vol.109 , pp. 1376-1383
    • Etienne, A.1    Esterni, B.2    Charbonnier, A.3    Mozziconacci, M.J.4    Arnoulet, C.5    Coso, D.6
  • 8
    • 1542753559 scopus 로고    scopus 로고
    • Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
    • Cheson BD, Bennett JM, Kopecky KJ, Buchner T, Willman CL, Estey EH, et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol 2003;21:4642-9.
    • (2003) J Clin Oncol , vol.21 , pp. 4642-4649
    • Cheson, B.D.1    Bennett, J.M.2    Kopecky, K.J.3    Buchner, T.4    Willman, C.L.5    Estey, E.H.6
  • 9
    • 34948866783 scopus 로고    scopus 로고
    • Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning
    • Kahl C, Storer BE, Sandmaier BM, Mielcarek M, Maris MB, Blume KG, et al. Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood 2007;110:2744-8.
    • (2007) Blood , vol.110 , pp. 2744-2748
    • Kahl, C.1    Storer, B.E.2    Sandmaier, B.M.3    Mielcarek, M.4    Maris, M.B.5    Blume, K.G.6
  • 10
    • 0343045296 scopus 로고    scopus 로고
    • Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy - the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: Final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group
    • Lowenberg B, Suciu S, Archimbaud E, Haak H, Stryckmans P, de Cataldo R, et al. Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy - the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group. J Clin Oncol 1998; 16:872-81.
    • (1998) J Clin Oncol , vol.16 , pp. 872-881
    • Lowenberg, B.1    Suciu, S.2    Archimbaud, E.3    Haak, H.4    Stryckmans, P.5    de Cataldo, R.6
  • 11
    • 0035437132 scopus 로고    scopus 로고
    • Postremission therapy in older patients with de novo acute myeloid leukemia: A randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine
    • Stone RM, Berg DT, George SL, Dodge RK, Paciucci PA, Schulman PP, et al. Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine. Blood 2001;98:548-53.
    • (2001) Blood , vol.98 , pp. 548-553
    • Stone, R.M.1    Berg, D.T.2    George, S.L.3    Dodge, R.K.4    Paciucci, P.A.5    Schulman, P.P.6
  • 12
    • 34250157761 scopus 로고    scopus 로고
    • Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: Results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial
    • Gardin C, Turlure P, Fagot T, Thomas X, Terre C, Contentin N, et al. Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial. Blood 2007;109:5129-35.
    • (2007) Blood , vol.109 , pp. 5129-5135
    • Gardin, C.1    Turlure, P.2    Fagot, T.3    Thomas, X.4    Terre, C.5    Contentin, N.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.